-Economic and Political Weekly The key to improving the quality of healthcare services in India and reducing costs at the same time can be found by enacting legislation which lays down minimum standards of patient care. In the absence of such standards and the reluctance of health insurance companies to standardise either price or quality, healthcare services continue to be expensive and of doubtful quality. Developing standards of patient care by...
More »SEARCH RESULT
Small and marginal farmers in distress -R Ramakumar and Aparajita Bakshi
-The Hans India It is official now. New data released by the National Sample Survey Organisation (NSSO) for 2013 show that the agrarian distress in rural India is continuing, and even intensifying for small and marginal farmers. In the last decade, there has been much talk on inclusive growth, revival of growth rates in agriculture, higher public investment in agriculture and the doubling of agricultural credit. Yet, the new data show...
More »‘Nutritional intake grows in India’ -Rukmini S
-The Hindu However, the data says the implications are unclear Per capita calorie intake in India grew marginally for the first time in 30 years, new official data shows, and protein intake grew for the first time in over a decade. The National Sample Survey Office's (NSSO) 2011-12 data on Nutritional Intake was released earlier this week. The data shows that per capita calorie consumption rose to 2099 kilocalories per day in rural...
More »India third on black money list: report
-PTI Global Financial Integrity puts the cumulative illicit money moving out of the country at Rs 28 lakh crore in 10 years Washington: As India continues its pursuit of suspected black money stashed abroad, an international think-tank has ranked the country third globally with an estimated USD 94.76 billion (nearly Rs 6 lakh crore) illicit wealth outflows in 2012. As a result, the cumulative illicit money moving out of the country over a...
More »Generic drug makers get a boost from SC ruling -Ramnath Subbu
-The Hindu In a significant development for the pharmaceutical industry, the Supreme Court has rejected multinational Bayer's appeal to block production and sales of the low cost version of its kidney cancer drug, sorafenib tosylate (branded as Nexavar), by Natco Pharmaceuticals. Hyderabad-based Natco was granted the first and to date only compulsory licence (CL) by the government in 2012 to make and sell a patented drug at a fraction of the...
More »